170 related articles for article (PubMed ID: 21058498)
1. Commentary on opinion pieces re Australian human papillomavirus vaccine policy.
McIntyre P
Sex Health; 2010 Sep; 7(3):242-3. PubMed ID: 21058498
[No Abstract] [Full Text] [Related]
2. For debate: that Australia should continue using the quadrivalent vaccine.
Wain G
Sex Health; 2010 Sep; 7(3):235-7. PubMed ID: 21058496
[No Abstract] [Full Text] [Related]
3. For debate: that Australia should consider changing to the bivalent vaccine.
Stern PL
Sex Health; 2010 Sep; 7(3):238-41. PubMed ID: 21058497
[No Abstract] [Full Text] [Related]
4. A brief history of economic evaluation for human papillomavirus vaccination policy.
Beutels P; Jit M
Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer vaccine development.
Frazer IH
Sex Health; 2010 Sep; 7(3):230-4. PubMed ID: 20719210
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of the bivalent compared with the quadrivalent human papillomavirus vaccines in Taiwan.
Demarteau N; Tang CH; Chen HC; Chen CJ; Van Kriekinge G
Value Health; 2012; 15(5):622-31. PubMed ID: 22867770
[TBL] [Abstract][Full Text] [Related]
7. Fewer shots proposed to increase uptake of HPV vaccine.
Dorans K
Nat Med; 2010 Aug; 16(8):832-3. PubMed ID: 20689528
[No Abstract] [Full Text] [Related]
8. [Vaccination against human papillomaviridae. Expert correspondence no. 18 of 29 December 2006].
Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe
Gynakol Geburtshilfliche Rundsch; 2007; 47(2):101-2. PubMed ID: 17440273
[No Abstract] [Full Text] [Related]
9. [Vaccine against human papillomavirus : PATRICIA Study (PApilloma TRIal against Cancer In young Adults)].
Kaufmann AM; Nitschmann S
Internist (Berl); 2010 Mar; 51(3):410, 412-3. PubMed ID: 20127302
[No Abstract] [Full Text] [Related]
10. Advancements in the control of genital human papillomavirus infections and related diseases: highlighting Australia's role.
Garland SM; Brotherton JM; Fairley CK; Gertig DM; Saville M
Sex Health; 2010 Sep; 7(3):227-9. PubMed ID: 21058495
[No Abstract] [Full Text] [Related]
11. Unresolved questions concerning human papillomavirus infection and transmission: a modelling perspective.
Regan DG; Philp DJ; Waters EK
Sex Health; 2010 Sep; 7(3):368-75. PubMed ID: 20719229
[TBL] [Abstract][Full Text] [Related]
12. The evolution of cost-effective screening and prevention of cervical carcinoma: implications of the 2006 consensus guidelines and human papillomavirus vaccination.
Monk BJ; Herzog TJ
Am J Obstet Gynecol; 2007 Oct; 197(4):337-9. PubMed ID: 17904955
[No Abstract] [Full Text] [Related]
13. Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States.
Brisson M; Laprise JF; Chesson HW; Drolet M; Malagón T; Boily MC; Markowitz LE
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26438574
[TBL] [Abstract][Full Text] [Related]
14. The cost effectiveness of a quadrivalent human papillomavirus vaccine (6/11/16/18) in Hungary.
Dasbach EJ; Nagy L; Brandtmüller A; Elbasha EH
J Med Econ; 2010 Mar; 13(1):110-8. PubMed ID: 20085477
[TBL] [Abstract][Full Text] [Related]
15. Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles.
Capri S; Gasparini R; Panatto D; Demarteau N
Gynecol Oncol; 2011 Jun; 121(3):514-21. PubMed ID: 21334734
[TBL] [Abstract][Full Text] [Related]
16. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy.
Brotherton JM; Kaldor JM; Garland SM
Sex Health; 2010 Sep; 7(3):310-9. PubMed ID: 20719220
[TBL] [Abstract][Full Text] [Related]
17. Cytology and cervical cancer surveillance in an era of human papillomavirus vaccination.
Budd AC; Sturrock CJ
Sex Health; 2010 Sep; 7(3):328-34. PubMed ID: 20719223
[TBL] [Abstract][Full Text] [Related]
18. Global human papillomavirus vaccination: can it be cost-effective?
Crosbie EJ
BJOG; 2012 Jan; 119(2):125-8. PubMed ID: 22168760
[No Abstract] [Full Text] [Related]
19. Genital human papillomavirus infections.
Kaliterna V; Barisic Z
Front Biosci (Landmark Ed); 2018 Mar; 23(9):1587-1611. PubMed ID: 29293452
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer: problem solved? Vaccinating girls against human papillomavirus.
Crosbie EJ; Brabin L
BJOG; 2010 Jan; 117(2):137-42. PubMed ID: 20050177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
